Synopsis
Inappropriate activation of the Wnt signaling pathway is observed in many human cancers and is sufficient to drive tumor initiation and progression in numerous contexts. Multiple mechanisms, such as overexpression of Wnt ligands, inactivation of the APC and Axin tumor suppressors, and mutation of -catenin, are responsible for pathway activation in tumor cells. The development of potent Wnt pathway antagonists for therapeutic use has been a major effort for investigators in both academia and industry in recent years. This book will provide an overview of the Wnt pathway as a therapeutic target for cancer, and discuss the preclinical development of inhibitors specifically directed to upstream and downstream components of the pathway.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Autres éditions populaires du même titre
Résultats de recherche pour Targeting the Wnt Pathway in Cancer
Image d'archives
Targeting the Wnt Pathway in Cancer (eng)
impression à la demandeVendeur : Brook Bookstore On Demand, Napoli, NA, Italie
Évaluation du vendeur 3 sur 5 étoiles
Etat : new. Questo è un articolo print on demand. N° de réf. du vendeur 29531a6761f8dec9173acdd8a868e0f3
Acheter neuf
EUR 126,26
Expédition à EUR 5,50
Expédition depuis Italie vers Etats-Unis
Expédition depuis Italie vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Targeting the Wnt Pathway in Cancer.
Edité par
New York: Springer, 2011
ISBN 10 : 1441980229
ISBN 13 : 9781441980229
Ancien ou d'occasion
Couverture rigide
Vendeur : Borkert, Schwarz und Zerfaß GbR, Berlin, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Etat : Wie neu. 239 S. Tadellos, nahezu ohne Gebrauchsspuren. - Inhalt: An Introduction to Wnt Signaling / Paul Polakis -- Regulation of Wnt Secretion and Distribution / Xiaofang Tang, Xiaolan Fan, and Xinhua Lin -- Wnt Signaling in Stem Cells / Philipp C. Manegold, Jia-Ling Teo, and Michael Kahn -- Crosstalk of the Wnt Signaling Pathway / Michael Thompson, Kari Nejak-Bowen, and Satdarshan P.S. Monga -- Dysregulation of the Wnt Pathway in Solid Tumors / Jenifer R. Prosperi, Hue H. Luu, and Kathleen H. Goss -- WNT/ß-Catenin Signaling in Leukemia / Markus Müschen -- Use of Genetically Engineered Mouse Models in Identification and Validation of Therapeutic Targets for Colon Cancer / Masahiro Aoki and Makoto Mark Taketo -- Targeting Wnt Signalling in Cancer / Aliaksei Holik and Alan R. Clarke -- Inhibiting the Wnt Signaling Pathway with Small Molecules / Ho-Jin Lee, Xinxin Zhang, and Jie J. Zheng -- Targeting of Wnt Signaling Inside the Nucleus / Miki Shitashige and Tesshi Yamada. - The Wnt pathway is an evolutionarily conserved signaling network that is critical for mammalian development and adult tissue maintenance, and, importantly, hyperactivated in most human cancers. Almost two decades of study has confirmed that Wnt signaling is necessary and sufficient for cancer pathogenesis in multiple in vitro and in vivo models systems, suggesting that the pathway represents an attractive therapeutic target. Recent efforts have focused on innovative strategies to antagonize Wnt signaling at various levels of the pathway from attenuating the extracellular signaling through the Wnt receptors to modulating the catenin destruction complex to blocking catenin-mediated transcription. Many of these approaches have been largely successful in preclinical validation studies and have been met with considerable enthusiasm to move forward into clinical trials. In this book, we highlight the recent advances in our understanding of the complexity of the Wnt pathway, particularly its intricate regulation and cross-talk with other key signal transduction pathways in normal and tumor cells. As a way to comprehend the role of Wnt pathway activation in tumor initiation and progression, we discuss the importance of Wnt signaling in embryonic and tissue development and stem cell maintenance and self-renewal. The evidence for aberrant Wnt pathway activation in human solid and hematopoietic cancers, as well as a few of the genetic mouse models that mimic the Wnt pathway deregulation observed in some of these tumor types, is reviewed. Lastly, we summarize the current status of the development of Wnt pathway inhibitors, their efficacy in preclinical models and their potential as therapeutic agents for cancer. It is an exciting time in the Wnt signaling field one that represents a key crossroad between dissecting the molecular details of the pathway and translating that work into promising targeted tumor therapies that is likely to profoundly impact this research area for years to come. (Verlagstext). ISBN 9781441980229 Sprache: Deutsch Gewicht in Gramm: 550 Fadengehefteter Originalpappband. N° de réf. du vendeur 984479
Acheter D'occasion
EUR 110
Expédition à EUR 40
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
Targeting the Wnt Pathway in Cancer
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9781441980229_new
Acheter neuf
EUR 163,95
Expédition à EUR 13,83
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Targeting the Wnt Pathway in Cancer
Edité par
Springer New York Jan 2011, 2011
ISBN 10 : 1441980229
ISBN 13 : 9781441980229
Neuf
Couverture rigide
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Inappropriate activation of the Wnt signaling pathway is observed in many human cancers and is sufficient to drive tumor initiation and progression in numerous contexts. Multiple mechanisms, such as overexpression of Wnt ligands, inactivation of the APC and Axin tumor suppressors, and mutation of -catenin, are responsible for pathway activation in tumor cells. The development of potent Wnt pathway antagonists for therapeutic use has been a major effort for investigators in both academia and industry in recent years. This book will provide an overview of the Wnt pathway as a therapeutic target for cancer, and discuss the preclinical development of inhibitors specifically directed to upstream and downstream components of the pathway. 252 pp. Englisch. N° de réf. du vendeur 9781441980229
Acheter neuf
EUR 160,49
Expédition à EUR 23
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
Targeting the Wnt Pathway in Cancer
Edité par
Springer New York, 2011
ISBN 10 : 1441980229
ISBN 13 : 9781441980229
Neuf
Couverture rigide
Vendeur : moluna, Greven, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Gebunden. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Provides an overview of the Wnt pathway as a therapeutic target for cancerDiscusses the preclinical development of inhibitors specifically directed to upstream and downstream components of the pathwayIn-depth look at the Wnt pathway by recognized leaders in. N° de réf. du vendeur 4176499
Acheter neuf
EUR 136,16
Expédition à EUR 48,99
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Targeting the Wnt Pathway in Cancer
Edité par
Springer New York, 2011
ISBN 10 : 1441980229
ISBN 13 : 9781441980229
Neuf
Couverture rigide
Vendeur : preigu, Osnabrück, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. Targeting the Wnt Pathway in Cancer | Michael Kahn (u. a.) | Buch | xi | Englisch | 2011 | Springer New York | EAN 9781441980229 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. N° de réf. du vendeur 107152029
Acheter neuf
EUR 141,20
Expédition à EUR 70
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 5 disponible(s)
Image fournie par le vendeur
Targeting the Wnt Pathway in Cancer
Edité par
Springer New York, Springer New York Jan 2011, 2011
ISBN 10 : 1441980229
ISBN 13 : 9781441980229
Neuf
Couverture rigide
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Inappropriate activation of the Wnt signaling pathway is observed in many human cancers and is sufficient to drive tumor initiation and progression in numerous contexts. Multiple mechanisms, such as overexpression of Wnt ligands, inactivation of the APC and Axin tumor suppressors, and mutation of ¿-catenin, are responsible for pathway activation in tumor cells. The development of potent Wnt pathway antagonists for therapeutic use has been a major effort for investigators in both academia and industry in recent years. This book will provide an overview of the Wnt pathway as a therapeutic target for cancer, and discuss the preclinical development of inhibitors specifically directed to upstream and downstream components of the pathway.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 252 pp. Englisch. N° de réf. du vendeur 9781441980229
Acheter neuf
EUR 160,49
Expédition à EUR 60
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Targeting the Wnt Pathway in Cancer
Edité par
Springer New York, Springer US, 2011
ISBN 10 : 1441980229
ISBN 13 : 9781441980229
Neuf
Couverture rigide
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Inappropriate activation of the Wnt signaling pathway is observed in many human cancers and is sufficient to drive tumor initiation and progression in numerous contexts. Multiple mechanisms, such as overexpression of Wnt ligands, inactivation of the APC and Axin tumor suppressors, and mutation of -catenin, are responsible for pathway activation in tumor cells. The development of potent Wnt pathway antagonists for therapeutic use has been a major effort for investigators in both academia and industry in recent years. This book will provide an overview of the Wnt pathway as a therapeutic target for cancer, and discuss the preclinical development of inhibitors specifically directed to upstream and downstream components of the pathway. N° de réf. du vendeur 9781441980229
Acheter neuf
EUR 164,49
Expédition à EUR 62,74
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
Targeting the Wnt Pathway in Cancer
Vendeur : Books Puddle, New York, NY, Etats-Unis
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. pp. 254. N° de réf. du vendeur 262382349
Acheter neuf
EUR 233,60
Expédition à EUR 3,43
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 4 disponible(s)
Image d'archives
Targeting the Wnt Pathway in Cancer
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : Brand New. 1st edition. 240 pages. 9.25x6.25x0.75 inches. In Stock. N° de réf. du vendeur x-1441980229
Acheter neuf
EUR 233,62
Expédition à EUR 14,43
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 2 disponible(s)